CD4 and myeloid sarcoma: We first showed that exosomes derived from patients with MS have potentials to reduce the relative frequency of IFN-γ−IL-17A−Foxp3+CD4+ Treg cells in culture by inhibiting their differentiation from naive CD4+ T cells (Figs. 1 and 5).